Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for NASH
NCT00845845Phase 2Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Mar 2006
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3-acid triglycerides in Nonalcoholic steatohepatitis (NASH), sponsored by University of Illinois Chicago. Started Mar 2006; status: terminated.
02
Drugs
omega-3-acid triglycerides
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00845845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845845.